Eli Lilly’s Zepbound plus amylin drug led to major weight loss in mid-stage trial
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
Novo receives Singapore approval for Wegovy® as first treatment for MASH with liver fibrosis
ESSENCE trial data showed 63% of participants receiving semaglutide achieved steatohepatitis resolution without worsening of liver fibrosis, compared…
GLP-1 companies facing lawsuits over vision loss
Some GLP-1 companies facing lawsuits over rare condition causing vision loss Some of the companies that produce GLP-1…
Hundreds of lawsuits filed against some GLP-1 Makers over vision loss
Hundreds of Americans are suing GLP-1 drugmakers Novo Nordisk and Ely Lilly, saying they were not adequately warned…
The Semaglutide Cliff vs. a 10x Multiple: Is Novo Nordisk (NVO) a Value Trap or a Bargain?
Morgan Stanley has cut Novo Nordisk A/S (NYSE:NVO) to Underweight on September 11, 2026. Semaglutide, the underlying molecule…
Why dementia is preventable – and the new tools that can reduce your risk
Dementia news is almost relentlessly grim – a steady drumbeat of rising cases and elusive cures. More bad…
Has Novo Nordisk Finally Found the Catalyst That Could Flip the Script on Eli Lilly?
Novo Nordisk (NYSE: NVO) started the GLP-1 weight-loss revolution that is sweeping the world. Its Wegovy/Ozempic shot was…
Sun Pharma Requires High Court Approval for Semaglutide Tablet Launch Amid Patent Dispute, ETPharma
New Delhi: The Delhi High Court on Tuesday asked Sun Pharma Laboratories to take its prior approval before…
Amazon Is Bringing the Weight-Loss Drug Race to Medicare
This article first appeared on GuruFocus. Amazon.com Inc. (AMZN, Financials), the e-commerce and cloud-computing company, is expanding its…
Hairdressers selling ‘Ozempic’: SA’s wild weight loss market
A recent high-profile court judgment halting a Pretoria pharmacy from selling GLP-1 drugs at scale has seemingly done…
Lilly to file for next-gen obesity drug approval in early 2027
Investing.com — Eli Lilly announced Thursday it will file for approval of its next-generation obesity drug retatrutide in…
Does EU Approval of Wegovy Pill Change NVO’s Competitive Story?
Novo Nordisk NVO received a meaningful commercial boost last week after the European Commission approved the oral version of…